Editorial Comment:
Fecal microbiota transplantation as a possible treatment of irritable bowel syndrome.
In a retrospective, multicenter, longitudinal observational study, the response rates to
fecal microbiota transplantation as a treatment for recurrent C. difficile infection were determined a 30 and 90 days, and adverse events were registered.
Not exact matches
Prof. Severine Vermeire (KU Leuven / UZ Leuven): «In the future, gut bacteria may be used to help identify PSC patients with a more or less aggressive disease, or patients that may benefit from
microbiota - based therapies, such
as fecal microbiota transplantation or targeted pre - and probiotics.»
Human gut microbiome ** Competitively Selected Donor
Fecal Microbiota Transplantation: Butyrate Concentration and Diversity
as Measures of Donor Quality.
As the Director of Policy and Global Partnerships at OpenBiome, Carolyn Edelstein oversees OpenBiome's efforts to expand the availability of
Fecal Microbiota Transplantation overseas, present its work to the public, and contribute to the discourse on the regulation of fecal microb
Fecal Microbiota Transplantation overseas, present its work to the public, and contribute to the discourse on the regulation of fecal m
Microbiota Transplantation overseas, present its work to the public, and contribute to the discourse on the regulation of
fecal microb
fecal microbiotamicrobiota.
He is internationally respected
as an expert on
fecal microbiota transplantation (FMT) and helminthic therapy, and is a frequent author and lecturer.